Characterization of a Nanovaccine Platform Based on an α1,2- Mannobiose Derivative Shows Species-non-specific Targeting to Human, Bovine, Mouse, and Teleost Fish Dendritic Cells
Dendritic cells serve as the main immune cells that trigger the immune response. We developed a simple and cost-effective nanovaccine platform based on the α1′,2-mannobiose derivative for dendritic cell targeting. In previous work, we have formulated the α1,2-mannobiose-based nanovaccine platform wi...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
ACS Publications
2021
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/9742 https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.1c00048 https://doi.org/10.1021/acs.molpharmaceut.1c00048 |
Ejemplares similares: Characterization of a Nanovaccine Platform Based on an α1,2- Mannobiose Derivative Shows Species-non-specific Targeting to Human, Bovine, Mouse, and Teleost Fish Dendritic Cells
- Dendritic cell targeting in cultured fish in Argentina for vaccine development
- Effects of polydopamine-passivation on the optical properties of carbon dots and its potential use in vivo
- Nanogel-Mediated antigen delivery: Biocompatibility, immunogenicity, and potential for tailored vaccine design across species
- Hacia una vacuna contra el Coronavirus causante de la Covid-19
- Foot-and-mouth disease virus infection of dendritic cells triggers phosphorylation of ERK1/2 inducing class I presentation and apoptosis
- Galectin‐8 activates dendritic cells and stimulates antigen‐specific immune response elicitation